Press & Media

Press and News

Industry Features

Press and News

VC-backed Elucidata Raises $16 Million In Series A
27 Sep 2022 | By Malvika Maloo

Biotech firm Elucidata, backed by the likes of IvyCap Ventures and Hyperlane Venture, on Tuesday said it has raised $16 million in a series A round led by global investment firm, Eight Roads Ventures.

Read More
Elucidata Raises Seed Funding to Transform Drug Discovery and Accelerate Growth
June 18, 2018 11:20 AM Eastern Daylight Time

Big data-driven software platform reduces the time from experiment design to discovery through analysis and visualization of -omics drug discovery data.

Read More
Elucidata Joins the Tetra Partner Network to Fuel Machine Learning Initiatives in Life Sciences
November 21, 2022

BOSTON, Mass., Nov. 21, 2022 -- /PRNewswire/ – TetraScience, the Scientific Data Cloud company, announced today that Elucidata, whose data-centric platform Polly powers biological discovery with ML-ready biomedical data

Read More
Elucidata’s MLops platform boosts data quality for drug discovery
September 21, 2022 2:30 AM | By Shubham Sharma

From young startups to major conglomerates, almost every organization in the life sciences industry is looking at AI to drive R&D and come up with and therapies.

Read More
Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry
27 Sep, 2022, 07:35 ET

CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ -- Elucidata, a TechBio company that powers life science research & development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly,

Read More
Elucidata Raises $16 Million in Series A
September 28th, 2022 | by Kay Aloha Villamor in Series A

Elucidata, a Cambridge, MA-based TechBio company that powers life science research and development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it raised $16 million in Series A funding.

Read More
Biomedical Data Startup Elucidata Bags $16 Mn To Scale SaaS Platform Polly
27 Sep'22 | By Chetan Thathoo

The round was led by Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital

Read More
Elucidata raises $16 million in series A led by Eight Roads Ventures
Sep 28, 2022 / 12:31 PM IST

The funds raised will be used by Elucidata’s data-centric Machine Learning Operations (ML-Ops) platform, Polly to deepen product capabilities in translational drug research and allied markets,

Read More
Elucidata expanding aggressively in India
Jun 19 2019 | 2:50 PM IST

Elucidata, the data science start-up focused on making better drugs, faster, has announced its plans to double its workforce by 2019.

Read More
Elucidata expanding aggressively in India
Jun 19 2019, 14:38 IST

New Delhi [India] June 19 (ANI/NewsVoir): Elucidata, the data science start-up focused on making better drugs, faster, has announced its plan to double its workforce by 2019.

Read More

Featured Posts

Doing More with Moore: Biotech’s Tech Moment
Read More
Targeting Pheochromocytoma/ Paraganglioma with Polyamine Inhibitors
Read More
Polly by Elucidata as an Analysis Portal on Human Cell Atlas
Read More
How Polly’s Curated Biomedical Molecular Data Streamlines MLOps for Drug Discovery
Read More
Integrated Metabolomic and Transcriptomic Profiling Reveals Novel Activation-Induced Metabolic Networks in Human T cells
Read More
ChatGPT in Drug Discovery: Rise of Large Language Models
Read More
FAIR Data Infrastructure in Life Sciences R&D
Read More
The Role of Curated Data in Accelerating the Identification of Putative Drug Targets for Cancer Immunotherapies – Elucidata
Read More
Reducing Inference Time of Biomedical NER Tasks using Multi-task Learning
Read More
BigBIO: A Framework for Data-centric Biomedical Natural Language Processing
Read More
World’s AI for Drug Development Landscape: Focus on Asia
Read More
Extreme Tech Startup Spotlight: Elucidata
Read More
FAIR Annotation and Evaluation of RNA Sequencing and Microarray Data – Elucidata
Read More
Request Demo